Back to Search Start Over

Description and analysis of representative COVID-19 cases–A retrospective cohort study.

Authors :
Herrmann, Yannis
Starck, Tim
Brindl, Niall
Kitchen, Philip J.
Rädeker, Lukas
Sebastian, Jakob
Köppel, Lisa
Tobian, Frank
Souares, Aurélia
Mihaljevic, André L.
Merle, Uta
Hippchen, Theresa
Herth, Felix
Knorr, Britta
Welker, Andreas
Denkinger, Claudia M.
Source :
PLoS ONE; 7/30/2021, Vol. 16 Issue 7, p1-14, 14p
Publication Year :
2021

Abstract

Background: Most data on COVID-19 was collected in hospitalized cases. Much less is known about the spectrum of disease in entire populations. In this study, we examine a representative cohort of primarily symptomatic cases in an administrative district in Southern Germany. Methods: We contacted all confirmed SARS-CoV-2 cases in the administrative district. Consenting participants answered a retrospective survey either via a telephone, electronically or via mail. Clinical and sociodemographic features were compared between hospitalized and non-hospitalized patients. Additionally, we assessed potential risk factors for hospitalization and time to hospitalization in a series of regression models. Results: We included 897 participants in our study, 69% out of 1,305 total cases in the district with a mean age of 47 years (range 2–97), 51% of which were female and 47% had a pre-existing illness. The percentage of asymptomatic, mild, moderate (leading to hospital admission) and critical illness (requiring mechanical ventilation) was 54 patients (6%), 713 (79%), 97 (11%) and 16 (2%), respectively. Seventeen patients (2%) died. The most prevalent symptoms were fatigue (65%), cough (62%) and dysgeusia (60%). The risk factors for hospitalization included older age (OR 1.05 per year increase; 95% CI 1.04–1.07) preexisting lung conditions (OR 3.09; 95% CI 1.62–5.88). Female sex was a protective factor (OR 0.51; 95% CI 0.33–0.77). Conclusion: This representative analysis of primarily symptomatic COVID-19 cases confirms age, male sex and preexisting lung conditions but not cardiovascular disease as risk factors for severe illness. Almost 80% of infection take a mild course, whereas 13% of patients suffer moderate to severe illness. Trial registration: German Clinical Trials Register, DRKS00022926. URL: https://www.drks.de/drks_web/setLocale_EN.do [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
19326203
Volume :
16
Issue :
7
Database :
Complementary Index
Journal :
PLoS ONE
Publication Type :
Academic Journal
Accession number :
151664955
Full Text :
https://doi.org/10.1371/journal.pone.0255513